Median salary
$186,000
per year · annualized USD
Typical range
$150k – $228.1k
25th–75th percentile
Disclosing pay
21.8%
300 of 1,374 roles
Live roles
1,374
open right now
Salary distribution
annualized USD · disclosed rolesHighest-paying live roles
Global Chief Medical Officer
Sr. Medical Director/Executive Director, Early Clinical Development
Vice President, Clinical Development (Oncology & Molecular Diagnostics)
Executive Medical Director, Clinical Development
Executive Director, Global Medical Expert
Vice President, Global RWE and HEOR Strategy
Vice President, Compliance
Neurologist – Neuromuscular / EMG / Neurophys/ Industry Research (Outpatient, No Call) – Denver, CO
Top companies hiring
| Company | Median | Roles |
|---|---|---|
Revolution Medicines
|
$209,500 | 58 |
|
Natera
|
$207,650 | 17 |
Oruka Therapeutics
|
$208,500 | 16 |
Iterative Health
|
$125,000 | 15 |
Tango Therapeutics
|
$199,000 | 13 |
| ES eClinical Solutions | $155,500 | 12 |
Cogstate
|
$78,718 | 12 |
BridgeBio Pharma
|
$225,000 | 10 |
See every Clinical Trial role
Browse the live listings, or save this search and get alerted the moment a new one posts.
How much do Clinical Trial roles pay?
The median salary for Clinical Trial roles is $186,000 per year. Most pay falls between $150,000 (25th percentile) and $228,125 (75th percentile), with the broader 10th–90th percentile band running from $108,300 to $281,500.
These figures are computed live from 1,374 active Clinical Trial roles on JobsRadar, of which 300 (21.8%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid Clinical Trial roles include Legend Biotech US, Natera, IMVT Corporation and Ultragenyx Pharmaceutical.
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.